Bank Of New York Mellon Corp Teva Pharmaceutical Industries LTD Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $14.8 Million - $17.7 Million	1,865,767 New	1,865,767 $17 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $102,049 - $177,768	14,876 Added 0.81%	1,855,933 $15 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $253,407 - $357,104	-34,337 Reduced 1.83%	1,841,057 $13.8 Million
Q1 2022 May 11, 2022	BUY	$7.33 - $9.39 $211,983 - $271,558	28,920 Added 1.57%	1,875,394 $17.6 Million
Q4 2021 Feb 11, 2022	BUY	$7.9 - $10.19 $420,864 - $542,862	53,274 Added 2.97%	1,846,474 $14.8 Million
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $273,330 - $332,041	32,617 Added 1.85%	1,793,200 $17.5 Million
Q2 2021 Aug 11, 2021	SELL	$9.9 - $11.56 $1.8 Million - $2.1 Million	-182,087 Reduced 9.37%	1,760,583 $17.4 Million
Q1 2021 May 13, 2021	SELL	$10.34 - $12.81 $571,357 - $707,842	-55,257 Reduced 2.77%	1,942,670 $22.4 Million
Q4 2020 Feb 09, 2021	SELL	$8.61 - $11.04 $143,787 - $184,368	-16,700 Reduced 0.83%	1,997,927 $19.3 Million
Q3 2020 Nov 12, 2020	SELL	$8.57 - $12.69 $21,990 - $32,562	-2,566 Reduced 0.13%	2,014,627 $18.2 Million
Q2 2020 Aug 12, 2020	BUY	$8.12 - $13.12 $1.02 Million - $1.65 Million	125,519 Added 6.64%	2,017,193 $24.9 Million
Q1 2020 May 06, 2020	SELL	$6.69 - $13.45 $209,624 - $421,442	-31,334 Reduced 1.63%	1,891,674 $17 Million
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $414,942 - $681,191	-63,544 Reduced 3.2%	1,923,008 $18.8 Million
Q3 2019 Nov 07, 2019	BUY	$6.16 - $9.6 $189,309 - $295,027	30,732 Added 1.57%	1,986,552 $13.7 Million
Q2 2019 Aug 12, 2019	BUY	$8.12 - $15.72 $1.03 Million - $2 Million	127,204 Added 6.96%	1,955,820 $18.1 Million
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $2.28 Million - $2.93 Million	-146,422 Reduced 7.41%	1,828,616 $28.7 Million
Q4 2018 Feb 11, 2019	BUY	$14.59 - $23.84 $979,981 - $1.6 Million	67,168 Added 3.52%	1,975,038 $30.5 Million
Q3 2018 Nov 09, 2018	SELL	$21.06 - $25.65 $878,833 - $1.07 Million	-41,730 Reduced 2.14%	1,907,870 $0
Q2 2018 Aug 06, 2018	BUY	$16.77 - $24.71 $79,875 - $117,693	4,763 Added 0.24%	1,949,600 $47.4 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $2.62 Million - $3.46 Million	-156,817 Reduced 7.46%	1,944,837 $33.2 Million
Q4 2017 Feb 09, 2018	BUY	$11.23 - $19.1 $23.6 Million - $40.1 Million	2,101,654	2,101,654 $39.8 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$979 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$825 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$787 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$657 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$603 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account